Oncology Today with Dr Neil Love cover image

Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting with Dr Matthew Lunning

Oncology Today with Dr Neil Love

00:00

CRS Management and Tosyllizumab

I'm not sure that the jury is out on by T-cell engagers and the immediate necessity of tosyllizumab. 10 milligrams of dexamethasone is a heck of a lot cheaper and a heck of an lot more accessible than tosylzumab. We have to come as come together as a community to analyze the situation because you know if you're going to use this in I'll just pick a pick a town in Nebraska if you can use this in Grand Island Nebraska.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app